Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.

Exclusion Criteria

• •1. Combined surgery
• •2. Previous intraocular surgery
• •3. Previous corneal refractive surgeries less than 6 months before screening
• •4. Non Senile or non pre-senilecataract (e.g.: traumatic, pathological or congenital cataract)
• •5. Pupillary abnormalities (irregular, etc.)
• •6. Iris synechiae
• •7. Eye movement disorder (nystagmus, etc.)
• •8. Dacryocystitis and all other pathologies of tears drainage system
• •9. History of Inflammatory ocular disease (Iritis, uveitis, herpetic keratitis)
• •10. Corneal, epithelial, stromal or endothelial, residual or evolutionary disease (including corneal ulceration and superficial punctuate keratitis)
• •11. History of ocular traumatism, infection or inflammation within the last 3 months
• •12. Pseudo-exfoliation, exfoliative syndrome
• •13. Prior intravitreal injections within 7 days of the surgery
• •14. IOP over 25mmHg under treatment
• •15. Best corrected visual acuity \< 1/10
• •16. Patient already included in the study for phakoexeresis
• •17. History of ophthalmic surgical complication (cystoid macular oedema, etc.)
• •18. Diabetes mellitus
• •19. Surdity
• •20. Pakinsondisease
• •21. Excessive anxiety
• •22. Any other medical or surgical history, disorder or disease such as acute or chronic severe organic disease: hepatic, endocrine neoplasic, hematological diseases, severe psychiatric illness, relevant cardiovascular abnormalities (such as unstable angina, bradycardia, atrial fibrillation,uncontrolled hypertension: systolic blood pressure over 140 mm Hg, diastolic blood pressure over 90 mmHg) and/or any complicating factor or structural abnormality judged by the investigator to be incompatible with the study.
• •24. Pregnancy (positive pregnancy test), lactation
• •25. Women of childbearing potential without an acceptable effective method of contraception (oral contraceptive, intra-uterine device, subcutaneous contraceptive implant) until end of the study participation OR
• •27. Inability of patient and/or relatives to understand the study procedures and thus inability to give informed consent
• •28. Non-compliant patient and/or relatives (e.g. not willing to attend the follow-up visits, way of life interfering with compliance)
• •29. Participation in anotherclinicalstudy
• •30. Already included once in this study
• •31. Ward of court
• •32. Patient not covered by the Social Security